Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis
Introduction
In contrast to n − 6 polyunsaturated fatty acids (PUFA) such as arachidonic acid (AA) which mediate predominantly proinflammatory effects, the n − 3 docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are mostly anti-inflammatory. The n − 3 PUFAs were reported to be protective in animal models of Alzheimer’s and Parkinson’s disease, in the ischemia–reperfusion model of stroke, and more recently in spinal cord and traumatic brain injury models (Bailes and Mills, 2010, Bousquet et al., 2008, Calon et al., 2004, Lopez-Vales et al., 2010, Marcheselli et al., 2003). In human subjects, high intake of dietary DHA and EPA affected the expression of more than 1000 genes, reducing proinflammatory and atherogenic related gene expression (Bouwens et al., 2009). In patients with multiple sclerosis (MS), several studies reported lower levels of inflammatory cytokines and MMP9 and significant improvement in quality of life following 3–6 months of n − 3 fatty acids supplementation (Gallai et al., 1995, Shinto et al., 2009, Weinstock-Guttman et al., 2005).
Although MS etiology remains elusive, the pathology relies mainly on autoimmune mechanisms that involve activated antigen-specific T cells as major players in addition to macrophages, dendritic cells (DC) and B cells (Frohman et al., 2006, Slavin et al., 2010). Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for MS. Multiple T cell subsets including CD4+ Th1 and Th17, γδT cells, CD8+ and Treg have been shown to be involved in EAE, with Th1 and Th17 as major pathogenic cells (Slavin et al., 2010). DC play an essential role in antigen presentation and T cell activation in EAE, with CNS perivascular conventional/myeloid DC (cDC/mDC) activating myelin-specific T cells and inducing differentiation into encephalitogenic Th1/Th17 (Bailey et al., 2007, Slavin et al., 2010).
DC represent an essential cellular link between innate and adaptive immunity. DC are professional antigen presenting cells whose major role is the uptake, processing and presentation of antigens to naïve CD4+ and CD8+ T cells. Following antigen uptake, cDC mature, upregulating MHCII and co-stimulatory molecules, secreting various cytokines and chemokines, and acquiring a new chemokine receptor pattern which enables them to migrate to neighboring lymph nodes. CD4+ T cell activation and differentiation in vivo is mediated through cognate interactions of naïve T cells with antigen-presenting cells, primarily cDC, which provide signaling through MHCII/antigen complexes and costimulatory molecules. Cytokines secreted by mature cDC play an important role in CD4+ T cell differentiation, with IL-12 supporting Th1, and IL-6, TGFβ and IL-23 supporting Th17 differentiation. We and others reported that exposure to DHA maintains cDC stimulated with TLR ligands in an immature state characterized by low MHCII, CD40, CD80, CD86, and CCR7 expression, and lack of inflammatory cytokine production (Kong et al., 2010, Wang et al., 2007, Zapata-Gonzalez et al., 2008, Zeyda et al., 2005). In our previous study (Kong et al., 2010) we did not address the effects of DHA-treated cDC on T cell activation and differentiation. Here we report for the first time that exposure to DHA prevents cDC to induce antigen-specific naïve CD4+ T cells to differentiate into Th17 cells, and that DHA-treated DC arrest T cells in G0/G1 phase through increased expression of p27(kip1). We also report for the first time that dietary DHA reduces EAE disease severity and that this correlates with a significant reduction in both Th1 and Th17 cells in spleen and the CNS.
Section snippets
Mice
B10.A mice (I-Ek), C57BL/6 mice (H-2b), TCR-Cyt-5CC7-I/Rag1−/− transgenic (PCCF-specific TCR Tg; I-Ek) and C57BL/6-Tg (Tcra2D2, Tcrb2D2)1Kuch/J (MOG35–55 specific TCR) were purchased from Jackson Laboratory (Bar Harbor, ME) and Taconic (Hudson, NY). Transgenic mice were bred and maintained in the Temple University School of Medicine animal facility (Philadelphia, PA) under pathogen-free conditions. All mice used were between 6 and 10 weeks of age. Mice were handled and housed in accordance with
DHA prevents LPS-induced DC maturation and cytokine production
Purified CD11c+ bone marrow-derived DC were exposed to DHA for 24 h followed by LPS stimulation. In previous experiments we established the optimal dose of DHA as 50 μM (Kong et al., 2010). Twenty-four hours later we analyzed the levels of CD40, CD80, CD86, PD-L1, and PD-L2 by flow cytometry. In immature DC, DHA treatment inhibited the expression of MHCII and increased slightly the expression of CD40 and CD86 (Table 1). As reported previously, we found that DHA prevented the upregulation of
Discussion
Initially the anti-inflammatory effects of DHA and EPA have been attributed to the inhibition of cycloxygenase-mediated AA metabolism. However, recent studies established that DHA and EPA also alter the composition of lipid rafts in immune cells, act as ligands for nuclear receptors such as peroxisome proliferator-activated receptors (PPARs) and retinoid X receptors (RXR), and generate endogenous metabolites involved in the resolution of inflammation such as resolvins, docosatrienes and
Conflict of Interest
All authors declare that there are no conflicts of interest.
Acknowledgments
This study was supported by the following grants: NIH/NIAID 2RO1AI052306 and Pennsylvania CURE Tobacco Settlement Formula (DG).
References (54)
- et al.
Docosahexaenoic acid modulates the expression of T-bet and GATA-3 transcription factors, independently of PPARalpha, through suppression of MAP kinase activation
Biochimie
(2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection
Prostag. Leukotr. Ess. Fatty Acids
(2009)- et al.
Docosahexaenoic acid-enriched fish oil consumption modulates immunoglobulin responses to and clearance of enteric reovirus infection in mice
J. Nutr.
(2008) - et al.
Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells
Am. J. Clin. Nutr.
(2009) The relationship between the fatty acid composition of immune cells and their function
Prostag. Leukotr. Ess. Fatty Acids
(2008)- et al.
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model
Neuron
(2004) - et al.
Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n−3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis
J. Nutr.
(2005) - et al.
Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation
Prostag. Leukotr. Ess. Fatty Acids
(2009) - et al.
Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n−3 polyunsaturated fatty acids
J. Neuroimmunol.
(1995) - et al.
NFAT pulls the strings during CD4+ T helper cell effector functions
Blood
(2010)
Dietary (n−3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide
J. Nutr.
Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells
Neuroscience
P27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
Am. J. Pathol.
Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression
J. Biol. Chem.
Dietary polyunsaturated fatty acids modulate resistance to Mycobacterium tuberculosis in guinea pigs
J. Nutr.
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
Hum. Immunol.
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study
Neurochem. Int.
Fish oil-fed mice have impaired resistance to influenza infection
J. Nutr.
Omega−3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis
Prostag. Leukotr. Ess. Fatty Acids
Dietary (n−3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection
J. Nutr.
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype
Blood
Omega−3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38
Nutrition
Low fat dietary intervention with omega−3 fatty acid supplementation in multiple sclerosis patients
Prostag. Leukotr. Ess. Fatty Acids
Reduction of inflammation and chronic tissue damage by omega−3 fatty acids in fat-1 transgenic mice with pancreatitis
Biochim. Biophys. Acta
Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells
J. Lipid Res.
Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation
J. Biol. Chem.
Resolvin E1, an endogenous lipid mediator derived from omega−3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
Proc. Natl. Acad. Sci. USA
Cited by (113)
Role of omega-3 endocannabinoids in the modulation of T-cell activity in a multiple sclerosis experimental autoimmune encephalomyelitis (EAE) model
2023, Journal of Biological ChemistryImmune regulation of poly unsaturated fatty acids and free fatty acid receptor 4
2023, Journal of Nutritional BiochemistryThe influence of phytochemicals on cell heterogeneity in chronic inflammation-associated diseases: the prospects of single cell sequencing
2022, Journal of Nutritional BiochemistryOmega-3 and cardiovascular prevention – Is this still a choice?
2022, Pharmacological ResearchDocosahexaenoic acid ameliorates autoimmune inflammation by activating GPR120 signaling pathway in dendritic cells
2021, International Immunopharmacology